Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyAmyloidosisTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
March 13
 · 
Be the first to react
A MyAmyloidosisTeam Member

I just got approved for Vyndamax and will get it in five days! Our co-pay is $45 each quarter or $180 annually. We feel so blessed! Hang in there and...

Live ON!

Auf gehts!

April 3
MyAmyloidosisTeam

Can Medicare approve both Vyndamax (tafamidis) and Amvuttra (vutrisiran) for ATTR amyloidosis treatment?

Your doctor's concern makes sense, as Medicare coverage for ATTR medications can be complex and varies by how the drugs are covered under different Medicare parts.

Medicare covers Amvuttra under Part B (medical Show Full Answer

Can Medicare approve both Vyndamax (tafamidis) and Amvuttra (vutrisiran) for ATTR amyloidosis treatment?

Your doctor's concern makes sense, as Medicare coverage for ATTR medications can be complex and varies by how the drugs are covered under different Medicare parts.

Medicare covers Amvuttra under Part B (medical coverage), which typically handles medications given by injection or infusion in a medical setting. However, Medicare Part D coverage for tafamidis formulations varies by state - some states don't currently cover Vyndamax under Part D, while most states do cover Vyndaqel (another form of tafamidis).

The combination of these two medications may require prior authorization, where your doctor would need to prove that both treatments together are medically necessary for your specific condition. This involves submitting paperwork explaining why you need both medications rather than just one.

If Medicare denies coverage for using both medications together, you have the right to appeal that decision. Your insurance must explain why coverage was denied, how to appeal, and your deadlines.

Additionally, both drug manufacturers offer patient assistance programs that might help with costs, though federal programs like Medicare are legally prohibited from using manufacturer copay cards. Your doctor or a patient access coordinator can help navigate these options and work on getting approval for the combination therapy if it's what you need.

March 13
A MyAmyloidosisTeam Member

Many thanks for your input!

March 27
A MyAmyloidosisTeam Member

While Amvuttra is very effective medication at silencing the production of the protein, it appears to only reduce levels by 88%. There is no current knowledge as to whether the immune system can then eliminate these remaining misfolded proteins. There is a clinical trial that will be addressing the effectiveness of the combination therapy, but there is currently little data on this.

March 27
A MyAmyloidosisTeam Member

What benefit did your doctor believe that the combination drug therapy would give you versus the single drug therapy?

March 26

Related Questions

View All
A MyAmyloidosisTeam Member asked a question 💭
Sturgeon Bay, WI

A MyAmyloidosisTeam Member asked a question 💭
Detroit, MI